vs
Side-by-side financial comparison of Canaan Inc. (CAN) and LIFECORE BIOMEDICAL, INC. \DE\ (LFCR). Click either name above to swap in a different company.
LIFECORE BIOMEDICAL, INC. \DE\ is the larger business by last-quarter revenue ($31.1M vs $20.8M, roughly 1.5× Canaan Inc.). Canaan Inc. runs the higher net margin — -18.4% vs -32.1%, a 13.7% gap on every dollar of revenue.
Canaan Inc., doing business as Canaan Creative and known simply as Canaan, is a Singapore-based computer hardware manufacturer. Established in 2013 by N.G. Zhang, Canaan specializes in Blockchain servers and ASIC microprocessors for use in bitcoin mining.
LIFECORE BIOMEDICAL, INC. is a biomedical firm focused on developing and manufacturing high-quality hyaluronic acid-based biomaterials. It operates three core segments: medical application products, pharmaceutical solutions, and personal care ingredients, with main markets spanning North America, Europe and the Asia-Pacific, supplying to leading medical device, pharmaceutical and cosmetic brand partners.
CAN vs LFCR — Head-to-Head
Income Statement — Q3 FY2025 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $20.8M | $31.1M |
| Net Profit | $-3.8M | $-10.0M |
| Gross Margin | 99.9% | 25.0% |
| Operating Margin | -15.9% | -9.9% |
| Net Margin | -18.4% | -32.1% |
| Revenue YoY | — | -4.5% |
| Net Profit YoY | — | -52.0% |
| EPS (diluted) | $-0.05 | $-0.29 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $20.8M | — | ||
| Q3 25 | $13.8M | $31.1M | ||
| Q2 25 | $11.4M | — | ||
| Q1 25 | — | $35.2M | ||
| Q4 24 | — | $32.6M | ||
| Q3 24 | $10.2M | $24.7M | ||
| Q2 24 | $4.8M | — | ||
| Q1 24 | — | $35.7M |
| Q4 25 | $-3.8M | — | ||
| Q3 25 | $-1.5M | $-10.0M | ||
| Q2 25 | $-11.9M | — | ||
| Q1 25 | — | $-14.8M | ||
| Q4 24 | — | $-6.6M | ||
| Q3 24 | $-10.4M | $-16.2M | ||
| Q2 24 | $-5.4M | — | ||
| Q1 24 | — | $15.6M |
| Q4 25 | 99.9% | — | ||
| Q3 25 | 99.9% | 25.0% | ||
| Q2 25 | 99.9% | — | ||
| Q1 25 | — | 28.0% | ||
| Q4 24 | — | 34.0% | ||
| Q3 24 | 99.9% | 21.8% | ||
| Q2 24 | 99.8% | — | ||
| Q1 24 | — | 33.3% |
| Q4 25 | -15.9% | — | ||
| Q3 25 | -27.0% | -9.9% | ||
| Q2 25 | -45.5% | — | ||
| Q1 25 | — | -25.7% | ||
| Q4 24 | — | -6.0% | ||
| Q3 24 | -77.2% | -46.9% | ||
| Q2 24 | -193.9% | — | ||
| Q1 24 | — | -2.5% |
| Q4 25 | -18.4% | — | ||
| Q3 25 | -11.0% | -32.1% | ||
| Q2 25 | -104.4% | — | ||
| Q1 25 | — | -42.0% | ||
| Q4 24 | — | -20.2% | ||
| Q3 24 | -102.7% | -65.7% | ||
| Q2 24 | -112.3% | — | ||
| Q1 24 | — | 43.8% |
| Q4 25 | $-0.05 | — | ||
| Q3 25 | $-0.02 | $-0.29 | ||
| Q2 25 | $-0.25 | — | ||
| Q1 25 | — | $-0.47 | ||
| Q4 24 | — | $-0.25 | ||
| Q3 24 | — | $-0.53 | ||
| Q2 24 | — | — | ||
| Q1 24 | — | $0.42 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $18.9M |
| Total DebtLower is stronger | $6.2M | $136.0M |
| Stockholders' EquityBook value | $52.4M | $-10.5M |
| Total Assets | $92.5M | $235.2M |
| Debt / EquityLower = less leverage | 0.12× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | — | ||
| Q3 25 | — | $18.9M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | $5.4M | ||
| Q4 24 | — | $9.5M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $6.2M | — | ||
| Q3 25 | $6.2M | $136.0M | ||
| Q2 25 | $6.2M | — | ||
| Q1 25 | — | $124.9M | ||
| Q4 24 | — | $111.3M | ||
| Q3 24 | — | $106.3M | ||
| Q2 24 | — | — | ||
| Q1 24 | — | $97.1M |
| Q4 25 | $52.4M | — | ||
| Q3 25 | $44.7M | $-10.5M | ||
| Q2 25 | $33.8M | — | ||
| Q1 25 | — | $2.2M | ||
| Q4 24 | — | $15.4M | ||
| Q3 24 | $43.6M | $-3.9M | ||
| Q2 24 | $56.8M | — | ||
| Q1 24 | — | $17.7M |
| Q4 25 | $92.5M | — | ||
| Q3 25 | $81.7M | $235.2M | ||
| Q2 25 | $78.0M | — | ||
| Q1 25 | — | $237.7M | ||
| Q4 24 | — | $255.4M | ||
| Q3 24 | $69.3M | $246.8M | ||
| Q2 24 | $73.7M | — | ||
| Q1 24 | — | $246.2M |
| Q4 25 | 0.12× | — | ||
| Q3 25 | 0.14× | — | ||
| Q2 25 | 0.18× | — | ||
| Q1 25 | — | 56.05× | ||
| Q4 24 | — | 7.20× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 5.49× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $1.8M |
| Free Cash FlowOCF − Capex | — | $25.0K |
| FCF MarginFCF / Revenue | — | 0.1% |
| Capex IntensityCapex / Revenue | — | 5.6% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-16.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | — | ||
| Q3 25 | — | $1.8M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | $1.2M | ||
| Q4 24 | — | $-6.1M | ||
| Q3 24 | — | $-613.0K | ||
| Q2 24 | — | — | ||
| Q1 24 | — | $-1.4M |
| Q4 25 | — | — | ||
| Q3 25 | — | $25.0K | ||
| Q2 25 | — | — | ||
| Q1 25 | — | $-4.3M | ||
| Q4 24 | — | $-8.6M | ||
| Q3 24 | — | $-4.0M | ||
| Q2 24 | — | — | ||
| Q1 24 | — | $-7.8M |
| Q4 25 | — | — | ||
| Q3 25 | — | 0.1% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | -12.1% | ||
| Q4 24 | — | -26.3% | ||
| Q3 24 | — | -16.3% | ||
| Q2 24 | — | — | ||
| Q1 24 | — | -21.8% |
| Q4 25 | — | — | ||
| Q3 25 | — | 5.6% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 15.5% | ||
| Q4 24 | — | 7.5% | ||
| Q3 24 | — | 13.9% | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 17.8% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | -0.09× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CAN
Segment breakdown not available.
LFCR
| Transferred At Point In Time | $26.6M | 85% |
| Transferred Over Time | $4.5M | 15% |
